HOOKIPA PHARMA INC. Pre-Tax Income
HOOKIPA PHARMA INC. reported Pre-Tax Income of -$15.43 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2025-05-15
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-03-31 was -$15.43M, a 207.26% decline year-over-year.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-12-31 was -$25.06M.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-09-30 was -$13.84M.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-06-30 was -$19.09M.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$43.61M.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$81.21M.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$64.69M.
- HOOKIPA PHARMA INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$75.66M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$15.43M 10-Q · filed 2025-05-15 | -$40.48M derived: sum of 2 quarters · filed 2025-05-15 | -$54.32M derived: sum of 3 quarters · filed 2025-05-15 | -$73.42M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | -$25.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$38.90M derived: sum of 2 quarters · filed 2025-02-28 | -$57.99M derived: sum of 3 quarters · filed 2025-02-28 | -$43.61M 10-K · filed 2025-02-28 |
| 2024-09-30 | -$13.84M 10-Q · filed 2024-11-14 | -$32.94M derived: sum of 2 quarters · filed 2024-11-14 | -$18.55M 10-Q · filed 2024-11-14 | -$43.21M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | -$19.09M 10-Q · filed 2024-08-08 | -$4.71M 10-Q · filed 2024-08-08 | -$29.37M derived: sum of 3 quarters · filed 2025-05-15 | -$48.43M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $14.38M 10-Q · filed 2025-05-15 | -$10.27M derived: sum of 2 quarters · filed 2025-05-15 | -$29.34M derived: sum of 3 quarters · filed 2025-05-15 | -$47.35M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$24.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$43.72M derived: sum of 2 quarters · filed 2025-02-28 | -$61.74M derived: sum of 3 quarters · filed 2025-02-28 | -$81.21M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$19.07M 10-Q · filed 2024-11-14 | -$37.08M derived: sum of 2 quarters · filed 2024-11-14 | -$56.56M 10-Q · filed 2024-11-14 | -$68.64M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$18.02M 10-Q · filed 2024-08-08 | -$37.49M 10-Q · filed 2024-08-08 | -$49.57M derived: sum of 3 quarters · filed 2025-02-28 | -$67.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$19.48M 10-Q · filed 2024-05-09 | -$31.56M derived: sum of 2 quarters · filed 2025-02-28 | -$49.84M derived: sum of 3 quarters · filed 2025-02-28 | -$66.19M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$30.36M derived: sum of 2 quarters · filed 2025-02-28 | -$46.72M derived: sum of 3 quarters · filed 2025-02-28 | -$64.69M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$18.28M 10-Q · filed 2023-11-09 | -$34.63M derived: sum of 2 quarters · filed 2023-11-09 | -$52.60M 10-Q · filed 2023-11-09 | -$73.84M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | -$16.36M 10-Q · filed 2023-08-10 | -$34.32M 10-Q · filed 2023-08-10 | -$55.56M derived: sum of 3 quarters · filed 2024-03-22 | -$75.60M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | -$17.97M 10-Q · filed 2023-05-11 | -$39.20M derived: sum of 2 quarters · filed 2024-03-22 | -$59.24M derived: sum of 3 quarters · filed 2024-03-22 | -$76.39M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | -$21.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$41.27M derived: sum of 2 quarters · filed 2024-03-22 | -$58.43M derived: sum of 3 quarters · filed 2024-03-22 | -$75.66M 10-K · filed 2024-03-22 |
| 2021-09-30 | -$20.04M 10-Q · filed 2022-11-14 | -$37.19M derived: sum of 2 quarters · filed 2022-11-14 | -$54.43M 10-Q · filed 2022-11-14 | -$66.90M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | -$17.15M 10-Q · filed 2022-08-11 | -$34.39M 10-Q · filed 2022-08-11 | -$46.87M derived: sum of 3 quarters · filed 2023-03-15 | -$60.45M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | -$17.24M 10-Q · filed 2022-05-16 | -$29.71M derived: sum of 2 quarters · filed 2023-03-15 | -$43.30M derived: sum of 3 quarters · filed 2023-03-15 | -$50.39M derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | -$12.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$26.06M derived: sum of 2 quarters · filed 2023-03-15 | -$33.16M derived: sum of 3 quarters · filed 2023-03-15 | -$44.08M 10-K · filed 2023-03-15 |
| 2020-09-30 | -$13.59M 10-Q · filed 2021-11-10 | -$20.68M derived: sum of 2 quarters · filed 2021-11-10 | -$31.61M 10-Q · filed 2021-11-10 | -$41.96M derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-06-30 | -$7.09M 10-Q · filed 2021-08-12 | -$18.02M 10-Q · filed 2021-08-12 | -$28.37M derived: sum of 3 quarters · filed 2022-03-24 | -$39.75M derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-03-31 | -$10.93M 10-Q · filed 2021-05-12 | -$21.28M derived: sum of 2 quarters · filed 2022-03-24 | -$32.66M derived: sum of 3 quarters · filed 2022-03-24 | -$44.63M derived: sum of 4 quarters · filed 2022-03-24 |
| 2019-12-31 | -$10.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$21.73M derived: sum of 2 quarters · filed 2022-03-24 | -$33.71M derived: sum of 3 quarters · filed 2022-03-24 | -$43.04M 10-K · filed 2022-03-24 |
| 2019-09-30 | -$11.38M 10-Q · filed 2020-11-12 | -$23.36M derived: sum of 2 quarters · filed 2020-11-12 | -$32.68M 10-Q · filed 2020-11-12 | -$34.58M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | -$11.98M 10-Q · filed 2020-08-13 | -$21.31M 10-Q · filed 2020-08-13 | -$23.20M derived: sum of 3 quarters · filed 2021-03-18 | -$27.15M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | -$9.33M 10-Q · filed 2020-05-14 | -$11.22M derived: sum of 2 quarters · filed 2021-03-18 | -$15.18M derived: sum of 3 quarters · filed 2021-03-18 | -$20.99M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$5.85M derived: sum of 2 quarters · filed 2021-03-18 | -$11.66M derived: sum of 3 quarters · filed 2021-03-18 | -$16.21M 10-K · filed 2021-03-18 |
| 2018-09-30 | -$3.95M 10-Q · filed 2019-11-12 | -$9.77M derived: sum of 2 quarters · filed 2019-11-12 | -$14.32M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$5.82M 10-Q · filed 2019-08-12 | -$10.37M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$4.55M 10-Q · filed 2019-05-20 | |||
| 2017-12-31 | -$12.72M 10-K · filed 2020-03-19 |